← Leaderboards
Mirac Nedim Ince
University Of Iowa
$1,115,140
Attributed
$1,115,140
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $377.5K · FY2009–24$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,115,140 · 2
VA$0 · 1
By mechanism
K08$737,640 · 1
R56$377,500 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Lois S Weisman$22,745,038
- Joel Vincent Weinstock$7,593,988
- Anil Kumar Chauhan$14,298,095
- Richard G. Lynch$640,554
- Chioma M Okeoma$5,616,688
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsRegulationT-LymphocyteGenerationsElementsSignal PathwayPreventPharmaceutical PreparationsResponseSignal TransductionTransforming Growth Factor BetaMediatingHelminthsImmunoregulationImmuneIntestinesPathway InteractionsExposure ToLeadImmune SystemGraft-Versus-Tumor InductionGeneticHematologic NeoplasmsMalignant Neoplasms
Grant awards (14)
Mixed Chimerism-Dependent Tolerance After Myeloablative Bone Marrow Transplantation$0
I01 · FY2024 · VA · contact PI
Mixed Chimerism-Dependent Tolerance After Myeloablative Bone Marrow Transplantation$0
I01 · FY2023 · VA · contact PI
Mixed Chimerism-Dependent Tolerance After Myeloablative Bone Marrow Transplantation$0
I01 · FY2022 · VA · contact PI
Mixed Chimerism-Dependent Tolerance After Myeloablative Bone Marrow Transplantation$0
I01 · FY2021 · VA · contact PI
Regulation of graft versus host disease with in vivo generated regulatory T cells$0
I01 · FY2020 · VA · contact PI
Regulation of graft versus host disease with in vivo generated regulatory T cells$0
I01 · FY2019 · VA · contact PI
Regulation of graft versus host disease with in vivo generated regulatory T cells$0
I01 · FY2018 · VA · contact PI
Regulation of graft versus host disease with in vivo generated regulatory T cells$0
I01 · FY2017 · VA · contact PI
Management of GVHD and GVT by in vivo generated regulatory T cells$377,500
R56 · FY2015 · AI · contact PI
The Role of Toll-like Receptor 4 Positive T Cells in Intestinal Immune Regulation$147,528
K08 · FY2013 · DK · contact PI
The Role of Toll-like Receptor 4 Positive T Cells in Intestinal Immune Regulation$147,528
K08 · FY2012 · DK · contact PI
The Role of Toll-like Receptor 4 Positive T Cells in Intestinal Immune Regulation$147,528
K08 · FY2011 · DK · contact PI
The Role of Toll-like Receptor 4 Positive T Cells in Intestinal Immune Regulation$147,528
K08 · FY2010 · DK · contact PI
The Role of Toll-like Receptor 4 Positive T Cells in Intestinal Immune Regulation$147,528
K08 · FY2009 · DK · contact PI